You searched for "HIV/AIDS"
3 results found
Professor and Harold and Muriel Block Chair in Pediatrics, Einstein
Professor, Microbiology & Immunology, Einstein
Professor, Obstetrics & Gynecology and Women, Einstein
Chief, Division of Pediatric Infectious Diseases, The Childrenâ€™s Hospital at Montefiore and Einstein
Human papillomavirus (HPV)Sexually transmitted infections (STI)
Dr. Herold is developing safe and effective topical microbicides for preventing HIV, genital herpes and other sexually transmitted infections. She is currently conducting NIH-funded studies to develop microbicide-releasing vaginal rings to prevent HIV transmission. read more...
Professor, Epidemiology & Population Health
Dr. Shoshanah Trachtenberg Frackman Faculty Scholar in Biomedical Ethics
BioethicsMultinational researchEthics in reproductive healthBioethics of research involving human subjectsGlobal health
Dr. Macklin is considered one of the founders of the field of bioethics. In a career dating to the early seventies, Dr. Macklin has lectured and published widely on a variety of medical ethics topics, including research using human subjects, global health, stem cell research, reproductive health, public health ethics, end-of-life issues and HIV/AIDS. She is a past president of the International Association of Bioethics and currently serves on its board of directors. read more...
Professor, Medicine (General Internal Medicine)
Associate Chief, General Internal Medicine, Department of Medicine
Director, General Internal Medicine Fellowship Program, Department of Medicine
Attending Physician, General Internal Medicine, Montefiore Health System
Opioid prescription guidelinesDrug addiction and treatmentDrug use in HIV-infected patients
Dr. Cunningham is a physician whose research centers on drug addiction and treatment, particularly opioid addiction and the use of buprenorphine for treatment. She currently serves on the NYC Mayor’s Heroin and Prescription Opioid Public Awareness Task Force and was a member of the CDC's Opioid Guideline Workgroup, which issued recommendations for tighter prescription guidelines in March 2016. read more...